Antitumor activity of artemisinin and its derivatives: From a well-known antimalarial agent to a potential anticancer drug

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Crespo Ortiz, Maria P ^a   Wei, Ming Q ^b  

^a UNIVERSIDAD SANTIAGO DE CALI   (Colombia)

^b GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTEMISONE; ARTEROLANE; ARTESUNATE; BUTYRIC ACID; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DEFEROXAMINE; DIHYDROARTEMISININ; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; LENALIDOMIDE; MATRIX METALLOPROTEINASE; MELPHALAN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXALIPLATIN; PIRARUBICIN; PROTEIN BCL 2; TEMOZOLOMIDE; THALIDOMIDE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TOPOTECAN; TRANSCRIPTION FACTOR AP 1; UNINDEXED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BILE DUCT CARCINOMA; CANCER CELL CULTURE; CANCER INVASION; CANCER RESISTANCE; CELL CYCLE ARREST; CELL PROLIFERATION; CYTOTOXICITY; DNA DAMAGE; DRUG ANTAGONISM; DRUG FORMULATION; DRUG HALF LIFE; DRUG POTENTIATION; DRUG SYNTHESIS; DRUG TARGETING; GENE EXPRESSION; HUMAN; LIVER CELL CARCINOMA; METASTASIS; MICROARRAY ANALYSIS; NONHUMAN; OXIDATIVE STRESS; PRIMARY TUMOR; REVIEW; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT; ANIMAL; CANCER TRANSPLANTATION; CHEMICAL MODEL; CLINICAL TRIAL (TOPIC); MALARIA; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); TUMOR CELL LINE;

ANIMALS; ANTIMALARIALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; CLINICAL TRIALS AS TOPIC; HUMANS; MALARIA; MICE; MODELS, CHEMICAL; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; REACTIVE OXYGEN SPECIES;

EID: 84855554316     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/247597     Document Type: Review

References (145)

1. Hsiao W. L. W., Liu L., The role of traditional Chinese herbal medicines in cancer therapy from TCM theory to mechanistic insights Planta Medica 2010 76 11 1118 1131
2. Efferth T., Dunstan H., Sauerbrey A., Miyachi H., Chitambar C. R., The anti-malarial artesunate is also active against cancer International Journal of Oncology 2001 18 4 767 773
3. Woerdenbag H. J., Moskal T. A., Pras N., Malingré T. M., El-Feraly F. S., Kampinga H. H., Konings A. W. T., Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells Journal of Natural Products 1993 56 6 849 856 (Pubitemid 23195612)
4. Reungpatthanaphong P., Mankhetkorn S., Modulation of multidrug resistance by artemisinin, artesunate and dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines Biological and Pharmaceutical Bulletin 2002 25 12 1555 1561 (Pubitemid 39663669)
5. Efferth T., Saverbrey A., Olbrich A., Molecular modes of action of artesunate in tumour cell lines Molecular Pharmacology 2003 64 2 382 394 (Pubitemid 36910002)
6. Gordi T., Lepist E. I., Artemisinin derivatives: toxic for laboratory animals, safe for humans? Toxicology Letters 2004 147 2 99 107 (Pubitemid 38130178)
7. Dondorp A. M., Nosten F., Yi P., Das D., Phyo A. P., Tarning J., Lwin K. M., Ariey F., Hanpithakpong W., Lee S. J., Ringwald P., Silamut K., Imwong M., Chotivanich K., Lim P., Herdman T., An S. S., Yeung S., Singhasivanon P., Day N. P. J., Lindegardh N., Socheat D., White N. J., Artemisinin resistance in Plasmodium falciparum malaria New England Journal of Medicine 2009 361 5 455 467
8. Qinghaosu Antimalaria Coordinating Research Group, Antimalaria studies on Qinghaosu Chinese Medical Journal 1979 92 12 811 816
9. Ashton M., Sy N. D., van Huong N., Gordi T., Hai T. N., Huong D. X., Niu N. T., Cng L. D., Artemisinin kinetics and dynamics during oral and rectal treatment of uncomplicated malaria Clinical Pharmacology and Therapeutics 1998 63 4 482 493 (Pubitemid 28214972)
10. Li Q., Weina P. J., Milhous W. K., Pharmacokinetic and pharmacodynamic profiles of rapid-acting artemisinins in the antimalarial therapy Current Drug Therapy 2007 2 3 210 223
11. Haynes R. K., Chan H. W., Cheung M. K., Lam W. L., Soo M. K., Tsang H. W., Voerste A., Williams I. D., C-10 ester and ether derivatives of dihydroartemisinin-10- artesunate, preparation of authentic 10- artesunate, and of other ester and ether derivatives bearing potential aromatic intercalating groups at C-10 European Journal of Organic Chemistry 2002 2002 1 113 132
12. Klayman D. L., Qinghaosu (artemisinin): an antimalarial drug from China Science 1985 228 4703 1049 1055 (Pubitemid 15227365)
13. Haynes R. K., From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements Current Topics in Medicinal Chemistry 2006 6 5 509 537
14. Creek D. J., Charman W. N., Chiu F. C. K., Prankerd R. J., Dong Y., Vennerstrom J. L., Charman S. A., Relationship between antimalarial activity and heme alkylation for spiro- and dispiro-1,2,4-trioxolane antimalarials Antimicrobial Agents and Chemotherapy 2008 52 4 1291 1296 (Pubitemid 351521990)
15. Jefford C. W., New developments in synthetic peroxidic drugs as artemisinin mimics Drug Discovery Today 2007 12 11-12 487 495 (Pubitemid 46783690)
16. Ramirez A. P., Thomas A. M., Woerpel K. A., Preparation of bicyclic 1,2,4-trioxanes from, -unsaturated ketones Organic Letters 2009 11 3 507 510
17. Taylor D. K., Avery T. D., Greatrex B. W., Tiekink E. R. T., Macreadie I. G., Macreadie P. I., Humphries A. D., Kalkanidis M., Fox E. N., Klonis N., Tilley L., Novel endoperoxide antimalarials: synthesis, heme binding, and antimalarial activity Journal of Medicinal Chemistry 2004 47 7 1833 1839 (Pubitemid 38380927)
18. Jefford C. W., Velarde J., Bernardinelli G., Synthesis of tricyclic arteannuin-like compounds Tetrahedron Letters 1989 30 34 4485 4488 (Pubitemid 19223669)
19. Posner G. H., Chang Ho Oh, Gerena L., Milhous W. K., Extraordinarily potent antimalarial compounds: new, structurally simple, easily synthesized, tricyclic 1,2,4-trioxanes Journal of Medicinal Chemistry 1992 35 13 2459 2467
20. Meshnick S. R., Thomas A., Ranz A., Xu C. M., Pan H. Z., Artemisinin (qinghaosu): the role of intracellular hemin in its mechanism of antimalarial action Molecular and Biochemical Parasitology 1991 49 2 181 189
21. Olliaro P. L., Haynes R. K., Meunier B., Yuthavong Y., Possible modes of action of the artemisinin-type compounds Trends in Parasitology 2001 17 3 122 126 (Pubitemid 32422178)
22. O'Neill P. M., Barton V. E., Ward S. A., The molecular mechanism of action of artemisininthe debate continues Molecules 2010 15 3 1705 1721
23. Klonis N., Crespo-Ortiz M. P., Bottova I., Abu-Bakar N., Kenny S., Rosenthal P. J., Tilley L., Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion Proceedings of the National Academy of Sciences of the United States of America 2011 108 28 11405 11410
24. Shuhua X., Binggui S., Utzinger J., Chollet J., Tanner M., Ultrastructural alterations in adult Schistosoma mansoni caused by artemether Memorias do Instituto Oswaldo Cruz 2002 97 5 717 724 (Pubitemid 135746091)
25. Galal A. M., Ross S. A., ElSohly M. A., ElSohly H. N., El-Feraly F. S., Ahmed M. S., McPhail A. T., Deoxyartemisinin derivatives from photooxygenation of anhydrodeoxydihydroartemisinin and their cytotoxic evaluation Journal of Natural Products 2002 65 2 184 188 (Pubitemid 34171179)
26. Beekman A. C., Wierenga P. K., Woerdenbag H. J., Van Uden W., Pras N., Konings A. W.T., El-Feraly F. S., Galal A. M., Wikstrm H. V., Artemisinin-derived sesquiterpene lactones as potential antitumour compounds: cytotoxic action against bone marrow and tumour cells Planta Medica 1998 64 7 615 619 (Pubitemid 28481473)
27. Meunier B., Robert A., Heme as trigger and target for trioxane-containing antimalarial drugs Accounts of Chemical Research 2010 43 11 1444 1451
28. Mercer A. E., Maggs J. L., Sun X. M., Cohen G. M., Chadwick J., O'Neill P. M., Park B. K., Evidence for the involvement of carbon-centered radicals in the induction of apoptotic cell death by artemisinin compounds Journal of Biological Chemistry 2007 282 13 9372 9382 (Pubitemid 47104599)
29. Zhang S., Gerhard G. S., Heme mediates cytotoxicity from artemisinin and serves as a general anti-proliferation target PLoS ONE 2009 4 10
30. Berger T. G., Dieckmann D., Efferth T., Schultz E. S., Funk J. O., Baur A., Schuler G., Artesunate in the treatment of metastatic uveal melanomafirst experiences Oncology Reports 2005 14 6 1599 1603
31. Hamacher-Brady A., Stein H. A., Turschner S., Toegel I., Mora R., Jennewein N., Efferth T., Eils R., Brady N. R., Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production Journal of Biological Chemistry 2011 286 8 6587 6601
32. Singh N. P., Lai H. C., Artemisinin induces apoptosis in human cancer cells Anticancer Research 2004 24 4 2277 2280 (Pubitemid 39166306)
33. Lu J. J., Meng L. H., Shankavaram U. T., Zhu C. H., Tong L. J., Chen G., Lin L. P., Weinstein J. N., Ding J., Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells Biochemical Pharmacology 2010 80 1 22 30
34. Lu J. J., Chen S. M., Zhang X. W., Ding J., Meng L. H., The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells Investigational New Drugs 2010 7 1 8
35. Mercer A. E., Copple I. M., Maggs J. L., O'Neill P. M., Park B. K., The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials Journal of Biological Chemistry 2011 283 2 987 996
36. Lai H., Singh N. P., Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and holotransferrin Cancer Letters 1995 91 1 41 46
37. Lai H., Nakase I., Lacoste E., Singh N. P., Sasaki T., Artemisinin-transferrin conjugate retards growth of breast tumors in the rat Anticancer Research 2009 29 10 3807 3810
38. Nakase I., Lai H., Singh N. P., Sasaki T., Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation International Journal of Pharmaceutics 2007 354 1-2 28 33 (Pubitemid 351400327)
39. Lai H., Sasaki T., Singh N. P., Targeted treatment of cancer with artemisinin and artemisinin-tagged iron-carrying compounds Expert Opinion on Therapeutic Targets 2005 9 5 995 1007 (Pubitemid 41488836)
40. Stockwin L. H., Han B., Yu S. X., Hollingshead M. G., Elsohly M. A., Gul W., Slade D., Galal A. M., Newton D. L., Artemisinin dimer anticancer activity correlates with heme-catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction International Journal of Cancer 2009 125 6 1266 1275
41. Huang X. J., Ma Z. Q., Zhang W. P., Lu Y. B., Wei E. Q., Dihydroartemisinin exerts cytotoxic effects and inhibits hypoxia inducible factor-1 activation in C6 glioma cells Journal of Pharmacy and Pharmacology 2007 59 6 849 856
42. Kwok J. C., Richardson D. R., The iron metabolism of neoplastic cells: alterations that facilitate proliferation? Critical Reviews in Oncology/Hematology 2002 42 1 65 78 (Pubitemid 34229148)
43. Efferth T., Benakis A., Romero M. R., Tomicic M., Rauh R., Steinbach D., Hfer R., Stamminger T., Oesch F., Kaina B., Marschall M., Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron Free Radical Biology and Medicine 2004 37 7 998 1009 (Pubitemid 39164582)
44. Xu Q., Li Z. -X., Peng H. -Q., Sun Z. -W., Cheng R. -L., Ye Z. -M., Li W. -X., Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line In vitro and In vivo Biomedicine and Biotechnology 2011 12 4 247 255
45. May W. S., Cuatrecasas P., Transferrin receptor: its biological significance Journal of Membrane Biology 1985 88 3 205 215 (Pubitemid 16173464)
46. Bostwick D. G., Alexander E. E., Singh R., Shan A., Qian J., Santella R. M., Oberley L. W., Yan T., Zhong W., Jiang X., Oberley T. D., Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer Cancer 2000 89 1 123 134 (Pubitemid 30451282)
47. Das U. N., A radical approach to cancer Medical Science Monitor 2002 8 4 RA79 RA92
48. Hansen J. B., Fisker N., Westergaard M., Kjrulff L. S., Hansen H. F., Thrue C. A., Rosenbohm C., Wissenbach M., rum H., Koch T., SPC3042: a proapoptotic survivin inhibitor Molecular Cancer Therapeutics 2008 7 9 2736 2745
49. Crespo M. D. P., Avery T. D., Hanssen E., Fox E., Robinson T. V., Valente P., Taylor D. K., Tilley L., Artemisinin and a series of novel endoperoxide antimalarials exert early effects on digestive vacuole morphology Antimicrobial Agents and Chemotherapy 2008 52 1 98 109
50. Ferreira I. D., Lopes D., Martinelli A., Ferreira C., Do Rosrio V. E., Cravo P., In vitro assessment of artesunate, artemether and amodiaquine susceptibility and molecular analysis of putative resistance-associated mutations of Plasmodium falciparum from So Tomé and Prncipe Tropical Medicine and International Health 2007 12 3 353 362 (Pubitemid 46280625)
51. Du J. H., Zhang H. D., Ma Z. J., Ji K. M., Artesunate induces oncosis-like cell death In vitro and has antitumor activity against pancreatic cancer xenografts In vivo Cancer Chemotherapy and Pharmacology 2010 65 5 895 902
52. Michaelis M., Kleinschmidt M. C., Barth S., Rothweiler F., Geiler J., Breitling R., Mayer B., Deubzer H., Witt O., Kreuter J., Doerr H. W., Cinatl J., Cinatl J., Anti-cancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines Biochemical Pharmacology 2010 79 2 130 136
53. Kim S. J., Kim M. S., Lee J. W., Lee C. H., Yoo H., Shin S. H., Park M. J., Lee S. H., Dihydroartemisinin enhances radiosensitivity of human glioma cells In vitro Journal of Cancer Research and Clinical Oncology. 2006 132 2 129 135
54. Lu Y. Y., Chen T. S., Wang X. P., Li L., Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques Journal of Biomedical Optics 2010 15 4 046028
55. Noori S., Hassan Z. M., Taghikhani M., Rezaei B., Habibi Z., Dihydroartemisinin can inhibit calmodulin, calmodulin-dependent phosphodiesterase activity and stimulate cellular immune responses International Immunopharmacology 2010 10 2 213 217
56. Mu D., Chen W., Yu B., Zhang C., Zhang Y., Qi H., Calcium and survivin are involved in the induction of apoptosis by dihydroartemisinin in human lung cancer SPC-A-1 cells Methods and Findings in Experimental and Clinical Pharmacology 2007 29 1 33 38 (Pubitemid 46447221)
57. Mu D., Zhang W., Chu D., Liu T., Xie Y., Fu E., Jin F., The role of calcium, P38 MAPK in dihydroartemisinin-induced apoptosis of lung cancer PC-14 cells Cancer Chemotherapy and Pharmacology 2008 61 4 639 645
58. Efferth T., Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin from bench to bedside Planta Medica 2007 73 4 299 309 (Pubitemid 46910410)
59. Riganti C., Doublier S., Viarisio D., Miraglia E., Pescarmona G., Ghigo D., Bosia A., Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1 and P-glycoprotein overexpression British Journal of Pharmacology 2009 156 7 1054 1066
60. Liu Y., Lok C. N., Ko B. C. B., Shum T. Y. T., Wong M. K., Che C. M., Subcellular localization of a fluorescent artemisinin derivative to endoplasmic reticulum Organic Letters 2010 12 7 1420 1423
61. Morrissey C., Gallis B., Solazzi J. W., Kim B. J., Gulati R., Vakar-Lopez F., Goodlett D. R., Vessella R. L., Sasaki T., Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cells Anti-Cancer Drugs 2010 21 4 423 432
62. Lu Y. Y., Chen T. S., Qu J. L., Pan W. L., Sun L., Wei X. B., Dihydroartemisinin (DHA) induces caspase-3-dependent apoptosis in human lung adenocarcinoma ASTC-a-1 cells Journal of Biomedical Science 2009 16 1, article 16
63. Gravett A. M., Liu W. M., Krishna S., Chan W. C., Haynes R. K., Wilson N. L., Dalgleish A. G., In vitro study of the anti-cancer effects of artemisone alone or in combination with other chemotherapeutic agents Cancer Chemotherapy and Pharmacology 2010 569 577
64. McDonald 3rd. E.R. E. R., El-Deiry W. S., Cell cycle control as a basis for cancer drug development (Review) International Journal of Oncology 2000 16 5 871 886
65. Vogelstein B., Kinzler K. W., Cancer genes and the pathways they control Nature Medicine 2004 10 8 789 799 (Pubitemid 39070849)
66. Woerdenbag H. J., Moskal T. A., Pras N., Malingré T. M., El-Feraly F. S., Kampinga H. H., Konings A. W. T., Cytotoxicity of artemisinin-related endoperoxides to Ehrlich ascites tumor cells Journal of Natural Products 1993 56 6 849 856 (Pubitemid 23195612)
67. Hou J., Wang D., Zhang R., Wang H., Experimental therapy of hepatoma with artemisinin and Its derivatives: In vitro and In vivo activity, chemosensitization, and mechanisms of action Clinical Cancer Research 2008 14 17 5519 5530
68. Yao L., Xie H., Jin Q.-Y., Hu W.-L., Chen L.-J., Analyzing anti-cancer action mechanisms of dihydroartemisinin using gene chip China Journal of Chinese Materia Medica 2008 33 13 1583 1586
69. Jiao Y., Ge C. M., Meng Q. H., Cao J. P., Tong J., Fan S. J., Dihydroartemisinin is an inhibitor of ovarian cancer cell growth Acta Pharmacologica Sinica 2007 28 7 1045 1056 (Pubitemid 47020494)
70. Malumbres M., Barbacid M., To cycle or not to cycle: a critical decision in cancer Nature Reviews Cancer 2001 1 3 222 231 (Pubitemid 33741897)
71. Johnson D. G., Walker C. L., Cyclins and cell cycle checkpoints Annual Review of Pharmacology and Toxicology 1999 39 295 312 (Pubitemid 29222561)
72. Firestone G. L., Sundar S. N., Anticancer activities of artemisinin and its bioactive derivatives Expert Reviews in Molecular Medicine 2009 11 e32
73. Ji Y., Zhang Y. C., Pei L. B., Shi L. L., Yan J. L., Ma X. H., Anti-tumor effects of dihydroartemisinin on human osteosarcoma Molecular and Cellular Biochemistry 2011 351 1-2 99 108
74. Chen H., Sun B., Pan S., Jiang H., Sun X., Dihydroartemisinin inhibits growth of pancreatic cancer cells In vitro and In vivo Anti-Cancer Drugs 2009 20 2 131 140
75. Aung W., Sogawa C., Furukawa T., Saga T., Anticancer effect of dihydroartemisinin (DHA) in a pancreatic tumor model evaluated by conventional methods and optical imaging Anticancer Research 2011 31 5 1549 1558
76. Wang S. -J., Sun B., Cheng Z. -X., Zhou H. -X., Gao Y., Kong R., Chen H., Jiang H. -C., Pan S. -H., Xue D. -B., Bai X. -W., Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NF- B pathway. Cancer Chemotherapy and Pharmacology. In press
77. Chen T., Li M., Zhang R., Wang H., Dihydroartemisinin induces apoptosis and sensitizes human ovarian cancer cells to carboplatin therapy Journal of Cellular and Molecular Medicine 2009 13 7 1358 1370
78. Wang J., Guo Y., Zhang B. C., Chen Z. T., Gao J. F., Induction of apoptosis and inhibition of cell migration and tube-like formation by dihydroartemisinin in murine lymphatic endothelial cells Pharmacology 2007 80 4 207 218 (Pubitemid 47557254)
79. Cabello C. M., Lamore S. D., Bair III W. B., Qiao S., Azimian S., Lesson J. L., Wondrak G. T., The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis. Investigational New Drugs. In press
80. Handrick R., Ontikatze T., Bauer K. D., Freier F., Rbel A., Drig J., Belka C., Jendrossek V., Dihydroartemisinin induces apoptosis by a bak-dependent intrinsic pathway Molecular Cancer Therapeutics 2010 9 9 2497 2510
81. Hwang Y. P., Yun H. J., Kim H. G., Han E. H., Lee G. W., Jeong H. G., Suppression of PMA-induced tumor cell invasion by dihydroartemisinin via inhibition of PKC /Raf/MAPKs and NF- B/AP-1-dependent mechanisms Biochemical Pharmacology 2010 79 12 1714 1726
82. Zhou H. J., Wang W. Q., Wu G. D., Lee J., Li A., Artesunate inhibits angiogenesis and downregulates vascular endothelial growth factor expression in chronic myeloid leukemia K562 cells Vascular Pharmacology 2007 47 2-3 131 138 (Pubitemid 47095451)
83. Wang J., Zhang B., Guo Y., Li G., Xie Q., Zhu B., Gao J., Chen Z., Artemisinin inhibits tumor lymphangiogenesis by suppression of vascular endothelial growth factor C Pharmacology 2008 82 2 148 155
84. Zhou H. J., Zhang J. L., Li A., Wang Z., Lou X. E., Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas In vivo and inhibits murine Lewis lung carcinoma cell line growth In vitro Cancer Chemotherapy and Pharmacology 2010 66 1 21 29
85. Disbrow G. L., Baege A. C., Kierpiec K. A., Yuan H., Centeno J. A., Thibodeaux C. A., Hartmann D., Schlegel R., Dihydroartemisinin is cytotoxic to papillomavirus-expressing epithelial cells In vitro and In vivo Cancer Research 2005 65 23 10854 10861 (Pubitemid 41713353)
86. Lijuan W., Effect of artesunate on human endometrial carcinoma Journal of Medical Colleges of PLA 2010 25 3 143 151
87. Youns M., Efferth T., Reichling J., Fellenberg K., Bauer A., Hoheisel J. D., Gene expression profiling identifies novel key players involved in the cytotoxic effect of Artesunate on pancreatic cancer cells Biochemical Pharmacology 2009 78 3 273 283
88. Rasheed S. A. K., Efferth T., Asangani I. A., Allgayer H., First evidence that the antimalarial drug artesunate inhibits invasion and In vivo metastasis in lung cancer by targeting essential extracellular proteases International Journal of Cancer 2010 127 6 1475 1485
89. Li L. N., Zhang H. D., Yuan S. J., Yang D. X., Wang L., Sun Z. X., Differential sensitivity of colorectal cancer cell lines to artesunate is associated with expression of beta-catenin and E-cadherin European Journal of Pharmacology 2008 588 1 1 8
90. Li S., Xue F., Cheng Z., Yang X., Wang S., Geng F., Pan L., Effect of artesunate on inhibiting proliferation and inducing apoptosis of SP2/0 myeloma cells through affecting NF B p65 International Journal of Hematology 2009 90 4 513 521
91. Weifeng T., Feng S., Xiangji L., Changqing S., Zhiquan Q., Huazhong Z., Peining Y., Yong Y., Mengchao W., Xiaoqing J., Wan-yee L., Artemisinin inhibits In vitro and In vivo invasion and metastasis of human hepatocellular carcinoma cells Phytomedicine 2011 18 2-3 158 162
92. Wu J., Hu D., Yang G., Zhou J., Yang C., Gao Y., Zhu Z., Down-regulation of BMI-1 cooperates with artemisinin on growth inhibition of nasopharyngeal carcinoma cells Journal of Cellular Biochemistry 2011 112 7 1938 1948
93. Buommino E., Baroni A., Canozo N., Petrazzuolo M., Nicoletti R., Vozza A., Tufano M. A., Artemisinin reduces human melanoma cell migration by down-regulating v 3 integrin and reducing metalloproteinase 2 production Investigational New Drugs 2008 27 5 412 418
94. Wang S. J., Gao Y., Chen H., Kong R., Jiang H. C., Pan S. H., Xue D. B., Bai X. W., Sun B., Dihydroartemisinin inactivates NF- B and potentiates the anti-tumor effect of gemcitabine on pancreatic cancer both In vitro and In vivo Cancer Letters 2010 293 1 99 108
95. Uren A. G., Wong L., Pakusch M., Fowler K. J., Burrows F. J., Vaux D. L., Choo K. H. A., Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype Current Biology 2000 10 21 1319 1328
96. Willoughby J. A., Sundar S. N., Cheung M., Tin A. S., Modiano J., Firestone G. L., Artemisinin blocks prostate cancer growth and cell cycle progression by disrupting Sp1 interactions with the cyclin-dependent kinase-4 (CDK4) promoter and inhibiting CDK4 gene expression Journal of Biological Chemistry 2009 284 4 2203 2213
97. Karnak D., Xu L., Chemosensitization of prostate cancer by modulating Bcl-2 family proteins Current Drug Targets 2010 11 6 699 707
98. Elmore S., Apoptosis: a review of programmed cell death Toxicologic Pathology 2007 35 4 495 516 (Pubitemid 46911891)
99. Efferth T., Glaisi M., Merling A., Krammer P. H., Li-Weber M., Artesunate induces ROS-mediated apoptosis in Doxorubicin-resistant T leukemia cells PLoS ONE 2007 2 8, article e693
100. He Q., Shi J., Shen X. L., An J., Sun H., Wang L., Hu Y. J., Sun Q., Fu L. C., Sheikh M. S., Huang Y., Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells Cancer Biology and Therapy 2010 9 10 817 823
101. Steeg P. S., Tumor metastasis: mechanistic insights and clinical challenges Nature Medicine 2006 12 8 895 904 (Pubitemid 44175140)
102. Duffy M. J., McGowan P. M., Gallagher W. M., Cancer invasion and metastasis: changing views Journal of Pathology 2008 214 3 283 293 (Pubitemid 351212383)
103. Hung W. C., Chang H. C., Indole-3-carbinol inhibits Sp1-induced matrix metalloproteinase-2 expression to attenuate migration and invasion of breast cancer cells Journal of Agricultural and Food Chemistry 2009 57 1 76 82
104. Hur E., Kim H. H., Choi S. M., Kim J. H., Yim S., Kwon H. J., Choi Y., Kim D. K., Lee M. O., Park H., Reduction of hypoxia-induced transcription through the repression of hypoxia-inducible factor-1 /aryl hydrocarbon receptor nuclear translocator DNA binding by the 90-kDa heat-shock protein inhibitor radicicol Molecular Pharmacology 2002 62 5 975 982 (Pubitemid 35222488)
105. Anfosso L., Efferth T., Albini A., Pfeffer U., Microarray expression profiles of angiogenesis-related genes predict tumor cell response to artemisinins Pharmacogenomics Journal 2006 6 4 269 278 (Pubitemid 44137954)
106. Chen H. H., Zhou H. J., Wang W. Q., Wu G. D., Antimalarial dihydroartemisinin also inhibits angiogenesis Cancer Chemotherapy and Pharmacology 2004 53 5 423 432
107. Huang X. J., Li C. T., Zhang W. P., Lu Y. B., Fang S. H., Wei E. Q., Dihydroartemisinin potentiates the cytotoxic effect of temozolomide in rat C6 glioma cells Pharmacology 2008 82 1 1 9
108. O'Connor R., The pharmacology of cancer resistance Anticancer Research 2007 27 3 A 1267 1272 (Pubitemid 46813088)
109. Chaijaroenkul W., Viyanant V., Mahavorasirikul W., Na-Bangchang K., Cytotoxic activity of artemisinin derivatives against cholangiocarcinoma (CL-6) and hepatocarcinoma (Hep-G2) cell lines Asian Pacific Journal of Cancer Prevention 2011 12 1 55 59
110. Singh N. P., Lai H. C., Synergistic cytotoxicity of artemisinin and sodium butyrate on human cancer cells Anticancer Research 2005 25 6 B 4325 4331 (Pubitemid 41665224)
111. Liu W. M., Gravett A. M., Dalgleish A. G., The antimalarial agent artesunate possesses anticancer properties that can be enhanced by combination strategies International Journal of Cancer 2011 128 6 1471 1480
112. Ohgami Y., Elstad C. A., Chung E., Shirachi D. Y., Quock R. M., Lai H. C., Effect of hyperbaric oxygen on the anticancer effect of artemisinin on molt-4 human leukemia cells Anticancer Research 2010 30 11 4467 4470
113. Witkowski B., Lelivre J., Barragn M. J.L., Laurent V., Su X. -Z., Berry A., Benoit-Vical F., Increased tolerance to artemisinin in Plasmodium falciparum is mediated by a quiescence mechanism Antimicrobial Agents and Chemotherapy 2010 54 5 1872 1877
114. Head J. F., Wang F., Elliott R. L., Antineoplastic drugs that interfere with iron metabolism in cancer cells Advances in Enzyme Regulation 1997 37 147 169 (Pubitemid 27371560)
115. Sertel S., Eichhorn T., Sieber S., Sauer A., Weiss J., Plinkert P. K., Efferth T., Factors determining sensitivity or resistance of tumor cell lines towards artesunate Chemico-Biological Interactions 2010 185 1 42 52
116. Bachmeier B., Fichtner I., Killian P. H., Kronski E., Pfeffer U., Efferth T., Development of resistance towards artesunate in MDA-MB-231 human breast cancer cells PLoS ONE 2011 6 5, article e20550
117. McLean W., Ward S. A., In vitro neurotoxicity of artemisinin derivatives Médecine Tropicale 1998 58 3 28 31
118. Schmuck G., Roehrdanz E., Haynes R. K., Kahl R., Neurotoxic mode of action of artemisinin Antimicrobial Agents and Chemotherapy 2002 46 3 821 827 (Pubitemid 34157669)
119. Kissinger E., Hien T. T., Hung N. T., Nam N. D., Tuyen N. L., Dinh B. V., Mann C., Phu N. H., Loc P. P., Simpson J. A., White N. J., Farrar J. J., Clinical and neurophysiological study of the effects of multiple doses of artemisinin on brain-stem function in vietnamese patients American Journal of Tropical Medicine and Hygiene 2000 63 1-2 48 55 (Pubitemid 32423094)
120. Si Y., Li Q., Xie L., Bennett K., Weina P. J., Mog S., Johnson T. O., Neurotoxicity and toxicokinetics of artelinic acid following repeated oral administration in rats International Journal of Toxicology 2007 26 5 401 410 (Pubitemid 350034889)
121. Efferth T., Kaina B., Toxicity of the antimalarial artemisinin and its dervatives Critical Reviews in Toxicology 2010 40 5 405 421
122. Singh N. P., Verma K. B., Case report of a laryngeal squamous cell carcinoma treated with artesunate Archive of Oncology 2002 10 4 279 280 (Pubitemid 36164142)
123. Singh N. P., Panwar V. K., Case report of a pituitary macroadenoma treated with artemether Integrative Cancer Therapies 2006 5 4 391 394 (Pubitemid 44722000)
124. Panossian L. A., Garga N. I., Pelletier D., Toxic brainstem encephalopathy after artemisinin treatment for breast cancer Annals of Neurology 2005 58 5 812 813 (Pubitemid 41552563)
125. Campos S., de la Cerda P., Rivera A., Fatal artesunate toxicity in a child Journal of Pediatric Infectious Diseases 2008 3 1 69 75 (Pubitemid 351541009)
126. Zhang Z. Y., Yu S. Q., Miao L. Y., Huang X. Y., Zhang X. P., Zhu Y. P., Xia X. H., Li D. Q., Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial Journal of Chinese Integrative Medicine 2008 6 2 134 138
127. Lee S., Synthesis of 10B-Substituited triazolyl artemisinins and their growth inhibitory activity against various cancer cells Bulletin of the Korean Chemical Society 2011 32 2 737 740
128. Feng F. S., Guantai E. M., Nell M. J., van Rensburg C. E. J., Hoppe H., Chibale K., Antiplasmodial and antitumor activity of dDHA analogs derived via the aza-Michael addition reaction Bioorganic and Medicinal Chemistry Letters 2000 21 10 2882 2886
129. Lee C. H., Hong H., Shin J., Jung M., Shin I., Yoon J., Lee W., NMR studies on novel antitumor drug candidates, deoxoartemisinin and carboxypropyldeoxoartemisinin Biochemical and Biophysical Research Communications 2000 274 2 359 369 (Pubitemid 30614324)
130. Alagbala A. A., McRiner A. J., Borstnik K., Labonte T., Chang W., D'Angelo J. G., Posner G. H., Foster B. A., Biological mechanisms of action of novel C-10 non-acetal trioxane dimers in prostate cancer cell lines Journal of Medicinal Chemistry 2006 49 26 7836 7842 (Pubitemid 46033673)
131. Horwedel C., Tsogoeva S. B., Wei S., Efferth T., Cytotoxicity of artesunic acid homo- and heterodimer molecules toward sensitive and multidrug-resistant CCRF-CEM leukemia cells Journal of Medicinal Chemistry 2010 53 13 4842 4848
132. Jeyadevan J. P., Bray P. G., Chadwick J., Mercer A. E., Byrne A., Ward S. A., Park B. K., Williams D. P., Cosstick R., Davies J., Higson A. P., Irving E., Posner G. H., O'Neill P. M., Antimalarial and Antitumor Evaluation of Novel C-10 Non-Acetal Dimers of 10 -(2-Hydroxyethyl)deoxoartemisinin Journal of Medicinal Chemistry 2004 47 5 1290 1298 (Pubitemid 38229131)
133. Jung M., Lee S., Ham J., Lee K., Kim H., Kie Kim S., Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer Journal of Medicinal Chemistry 2003 46 6 987 994 (Pubitemid 36423145)
134. Opsenica D., Pocsfalvi G., Juranic Z., Tinant B., Declercq J. P., Kyle D. E., Milhous W. K., Solaja B. A., Cholic acid derivatives as 1,2,4,5-tetraoxane carriers: structure and antimalarial and antiproliferative activity Journal of Medicinal Chemistry 2000 43 17 3274 3282
135. Soomro S., Langenberg T., Mahringer A., Konkimalla V. B., Horwedel C., Holenya P., Brand A., Cetin C., Fricker G., Dewerchin M., Carmeliet P., Conway E. M., Jansen H., Efferth T., Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties Journal of Cellular and Molecular Medicine 2011 15 5 1122 1135
136. de Vries P. J., Dien T. K., Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria Drugs 1996 52 6 818 836 (Pubitemid 26413293)
137. Krishna S., Uhlemann A. C., Haynes R. K., Artemisinins: mechanisms of action and potential for resistance Drug Resistance Updates 2004 7 4-5 233 244 (Pubitemid 39469096)
138. Charman S. A., Arbe-Barnes S., Bathurst I. C., Brund R., Campbell M., Charman W. N., Chiu F. C.K., Chollet J., Craft J. C., Creek D. J., Don Y., Matile H., Maurer M., Morizzi J., Nguyen T., Papastogiannidis P., Scheurer C., Shackleford D. M., Sriraghavan K., Stingelin L., Tang Y., Urwyler H., Wang X., White K. L., Wittlin S., Zhou L., Vennerstrom J. L., Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria Proceedings of the National Academy of Sciences of the United States of America 2011 108 11 4400 4405
139. Xiao S. -H., Keiser J., Chollet J., Utzinger J., Dong Y., Endriss Y., Vennerstrom J. L., Tanner M., In vitro and In vivo activities of synthetic trioxolanes against major human schistosome species Antimicrobial Agents and Chemotherapy 2007 51 4 1440 1445 (Pubitemid 46586827)
140. Opsenica I., Opsenica D., Smith K. S., Milhous W. K., olaja B. A., Chemical stability of the peroxide bond enables diversified synthesis of potent tetraoxane antimalarials Journal of Medicinal Chemistry 2008 51 7 2261 2266 (Pubitemid 351503281)
141. Terzi N., Opsenica D., Mili D., Tinant B., Smith K. S., Milhous W. K., olaja B. A., Deoxycholic acid-derived tetraoxane antimalarials and antiproliferatives Journal of Medicinal Chemistry 2007 50 21 5118 5127 (Pubitemid 47585709)
142. World Health Organization, Guidelines for the Treatment of Malaria 2006 Geneva, Switzerland WHO press
143. Yuen A. R., Zou G., Turrisi A. T., Sause W., Komaki R., Wagner H., Aisner S. C., Livingston R. B., Blum R., Johnson D. H., Reproductive functions in female patients treated with adjuvant and neoadjuvant chemotherapy for localized osteosarcoma of the extremity Cancer 2000 89 9 1961 1965
144. Wu Z. P., Gao C. W., Wu Y. G., Zhu Q. S., Chen Y., Liu X., Liu C.,
145. Cavallo F., de Giovanni C., Nanni P., Forni G., Lollini P. -L., 2011: the immune hallmarks of cancer Cancer Immunology, Immunotherapy 2011 60 3 319 326